Despite the impact of improvements in sanitation and the availability of antibiotics and vaccines, infectious diseases remain the leading cause of death worldwide (1). There are a number of emerging infections that threaten people’s health both locally and globally every year. Several factors can influence the appearance of emerging and re-emerging infectious diseases including ecological factors, globalization, microbial adaptation, and human behavior (2).
Recently, the outbreak of the severe acute respiratory syndrome coronavirus (SARS-CoV) -2, known as COVID-19, appeared in Wuhan and spread rapidly all over the world, reaching more than 13 millions people infected and 0.57 millions death worldwide until mid-July 2020 (3). Infection control focuses on quarantining infected people and restricting people’s mobility while a protective vaccine is ready or the threat disappears.
Globalization and the movement of people make new emerging pathogens spread throughout the world. Therefore, the scientific community needs to be prepared to put all its skills into finding ways to act quickly to minimize damage when the disaster happens. Technological advances and knowledge in life sciences allow us to have a straightforward approach to act in such situations. Such approaches could be organized and coordinated by administrations and health authorities that need to provide the scientific community in each country with the necessary resources to apply these approaches.
In this article, a direct approach was developed to apply when such situations arise. It consists of two simple materials used as a starting point that are later developed as key components against an infection. These are the immunogenic epitopes that induce the immune system and the antibodies against them produced by patients who have passed the infection.